« Health Reform Whitepaper: Employer Impact of PPACA | Main | Health Reform Whitepaper: Strengthening the Fraud and Abuse Laws »

07/19/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e551db42b488330133f265755a970b

Listed below are links to weblogs that reference Health Reform Update - Provider Impact:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

A subgroup in the trial noted that docosanol stopped cold sore episodes from progressing to the blister stage in 34% of patients who applied it at the early sign of an outbreak (redness) compared to 23% in the equivalent placebo group.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.